Atrial natriuretic factor in various stages of diabetic nephropathy

Richards, 1985, Renal, haemodynamic and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers, Lancet, 1, 545, 10.1016/S0140-6736(85)91207-3 Raine, 1986, Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure, N Engl J Med, 311, 533, 10.1056/NEJM198608283150901 Sagnella, 1986, Raised circulation levels of atrial natriuretic peptides in essential hypertension, Lancet, 1, 179, 10.1016/S0140-6736(86)90653-7 Mogensen, 1982, Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy, Br Med J, 285, 685, 10.1136/bmj.285.6343.685 Mühlhauser, 1983, Bicentric evaluation of teaching and treatment programme for Type 1 (insulin-dependent) diabetic patients: improvement of metabolic, control and other measures of diabetes care for up to 22 months, Diabetologia, 25, 470, 10.1007/BF00284453 Haase, 1986 Rascher, 1985, Atrial natriuretic peptide in plasma of volume overloaded children with chronic renal failure, Lancet, 2, 303, 10.1016/S0140-6736(85)90351-4 Smith, 1986, Role of atrial natriuretic peptide in adaptation of sodium excretion with reduced renal mass, J Clin Invest, 77, 1395, 10.1172/JCI112447 Ortola, 1987, Glomerular hyperfiltration in diabetic rats is associated with elevated circulating atrial natriuretic peptide (ANP) levels, Kidney Int, 31, 282 DeFronzo, 1981, The effect of insulin on renal sodium metabolism, Diabetologia, 21, 165, 10.1007/BF00252649 Christlieb, 1976, Plasma renin activity and hypertension in diabetes mellitus, Diabetes, 25, 969, 10.2337/diabetes.25.10.969 Hostetter, 1982, The case of intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies, Am J Med, 72, 375, 10.1016/0002-9343(82)90490-9